Literature DB >> 4098476

Alternate-dy prednisone in a patient with myasthenia gravis.

J R Warmolts, W K Engel, J N Whitaker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4098476     DOI: 10.1016/s0140-6736(70)90392-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis.

Authors:  N Wakata; Y Kawamura; M Kobayashi; Y Araki; M Kinoshita
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

Review 2.  Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors:  Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-01-22

3.  Endoscopic thymectomy: a neurologist's perspective.

Authors:  Roberta Ricciardi; Franca Melfi; Michelangelo Maestri; Anna De Rosa; Afroditi Petsa; Marco Lucchi; Alfredo Mussi
Journal:  Ann Cardiothorac Surg       Date:  2016-01

4.  Myasthenia gravis, ulcerative colitis and lichen planus.

Authors:  T N Miller
Journal:  Proc R Soc Med       Date:  1971-08

Review 5.  Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Authors:  Itay Lotan; Mark A Hellmann; Adi Wilf-Yarkoni; Israel Steiner
Journal:  J Neurol       Date:  2020-10-16       Impact factor: 6.682

6.  [Myasthenia gravis in a young dog (author's transl)].

Authors:  L Breton; Y Gosselin; L Couture
Journal:  Can Vet J       Date:  1981-10       Impact factor: 1.008

7.  Introducing corticosteroids therapy from 1969 to 1990 at the Centre/Institute for Neuromuscular Diseases, KBC Rebro, Zagreb, Croatia.

Authors:  Anica Jušić
Journal:  Acta Myol       Date:  2012-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.